Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies

<b>Objectives</b>: Cryoglobulinemia (CG) is marked by abnormal immunoglobulins (Ig) in serum, precipitating at temperatures below 37 °C. Current classification categorizes CG into three subtypes (types I, II, and III) based on Ig clonality. The features distinguishing patients with CG based on their etiology remain unidentified. Aiming to characterize clinical and serological profiles of CG individuals, we conducted an observational analysis of a large cohort of patients and compared their characteristics based on underlying causes: hepatovirus (HV) infections, rheumatic diseases (RD), hematological disorders, and unidentified etiology (essential CG). <b>Methods</b>: We analyzed 252 cryoglobulin-positive serum samples from 182 patients and classified these into the four etiological groups. A separate sub-analysis was carried out for 10 patients meeting criteria for multiple diseases. We collected demographic, clinical, and laboratory data: CG characterization, complement (C3 and C4) levels, antinuclear antibodies (ANA), and rheumatoid factor (RF). Kruskal-Wallis and Wilcoxon-Mann-Whitney <i>U-</i>tests were used for comparisons. <b>Results</b>: Most patients (93.3%) had mixed cryoglobulinemia (types II + III), with 6.7% having type I. HV infection, predominantly hepatitis C, was the main (52.9%) associated condition within the cohort, followed by rheumatic (27.3%) and hematological (9.8%) disorders. In our cohort, ANA were frequent (45.3%) and often associated with RF positivity (43.6%) and decreased complement levels (C3: 42.4%, C4: 32.5%). Essential CG and CG associated with RD had a higher prevalence of cutaneous manifestations (<i>p</i> < 0.01) and renal involvement (<i>p</i> = 0.017). Hematological disorder-related CG showed higher cryoglobulin and RF concentrations (<i>p</i> < 0.01), despite milder symptoms. <b>Conclusions</b>: Our study underscores a mixed prevalence of CG across disease subgroups, with hepatitis-C virus as the primary factor, followed by rheumatic and hematological disorders. Four clinical and serological profiles of CG were identified based on their etiologies.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2024-10-11
DOI
https://doi.org/10.3390/jcm13206069
Citations
6
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
2.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies

Patricia Moya, Ivan Castellvi, Elisabeth Moltó, Berta Magallares-López et al.
6 citations
Journal of Clinical Medicine
Chronic Lymphocytic Leukemia Research
2.63
article

Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies

Patricia Moya, Ivan Castellvi, Elisabeth Moltó, Berta Magallares-López, Hye Sang Park, Anaís Mariscal, Hèctor Corominas, Cèsar Díaz‐Torné, L. Sainz Comas, A. Laíz, Esther Moga, Helena Codes-Méndez, J. L. Tandaipan, Yolanda Álvaro, Sicylle Jeria
article en
6 citations

Abstract

<b>Objectives</b>: Cryoglobulinemia (CG) is marked by abnormal immunoglobulins (Ig) in serum, precipitating at temperatures below 37 °C. Current classification categorizes CG into three subtypes (types I, II, and III) based on Ig clonality. The features distinguishing patients with CG based on their etiology remain unidentified. Aiming to characterize clinical and serological profiles of CG individuals, we conducted an observational analysis of a large cohort of patients and compared their characteristics based on underlying causes: hepatovirus (HV) infections, rheumatic diseases (RD), hematological disorders, and unidentified etiology (essential CG). <b>Methods</b>: We analyzed 252 cryoglobulin-positive serum samples from 182 patients and classified these into the four etiological groups. A separate sub-analysis was carried out for 10 patients meeting criteria for multiple diseases. We collected demographic, clinical, and laboratory data: CG characterization, complement (C3 and C4) levels, antinuclear antibodies (ANA), and rheumatoid factor (RF). Kruskal-Wallis and Wilcoxon-Mann-Whitney <i>U-</i>tests were used for comparisons. <b>Results</b>: Most patients (93.3%) had mixed cryoglobulinemia (types II + III), with 6.7% having type I. HV infection, predominantly hepatitis C, was the main (52.9%) associated condition within the cohort, followed by rheumatic (27.3%) and hematological (9.8%) disorders. In our cohort, ANA were frequent (45.3%) and often associated with RF positivity (43.6%) and decreased complement levels (C3: 42.4%, C4: 32.5%). Essential CG and CG associated with RD had a higher prevalence of cutaneous manifestations (<i>p</i> < 0.01) and renal involvement (<i>p</i> = 0.017). Hematological disorder-related CG showed higher cryoglobulin and RF concentrations (<i>p</i> < 0.01), despite milder symptoms. <b>Conclusions</b>: Our study underscores a mixed prevalence of CG across disease subgroups, with hepatitis-C virus as the primary factor, followed by rheumatic and hematological disorders. Four clinical and serological profiles of CG were identified based on their etiologies.

Journal of Clinical MedicineVol. 13(20)
Universitat Autònoma de Barcelona (ES), Hospital de Sant Pau (ES), Institut de Recerca Sant Pau (ES)
Openalex Percentile: Top 10%
Chronic Lymphocytic Leukemia Research
2.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.